BLCM is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Bellicum Pharmaceuticals Inc has completed 1 stock splits, with the recent split occurring on Feb 06, 2020.
The company's stock is traded on 0 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).